Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

REPLIGEN CORPORATION

(RGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Insider Trends: Insider Sale at Repligen Slowing 90-Days of Buying

05/18/2021 | 07:53am EDT


ę MT Newswires 2021
All news about REPLIGEN CORPORATION
07/22INSIDER TRENDS : Repligen Insider Extends 90-Day Selling Trend
MT
07/13Repligen to Report Second Quarter 2021 Financial Results
GL
06/25REPLIGEN CORPORATION(NASDAQGS : RGEN) added to Russell 2500 Value Index
CI
06/25REPLIGEN CORPORATION(NASDAQGS : RGEN) added to Russell 3000E Value Index
CI
06/25REPLIGEN CORPORATION(NASDAQGS : RGEN) added to Russell Small Cap Comp Value Inde..
CI
06/25REPLIGEN CORPORATION(NASDAQGS : RGEN) added to Russell 1000 Value Index
CI
06/25REPLIGEN CORPORATION(NASDAQGS : RGEN) added to Russell Midcap Value Index
CI
06/25REPLIGEN CORPORATION(NASDAQGS : RGEN) added to Russell 3000 Value Index
CI
06/22REPLIGEN : To Buy Polymem For Undisclosed Sum
MT
06/22Repligen Corporation Announces Agreement to Acquire Polymem S.A.
GL
More news
Financials (USD)
Sales 2021 586 M - -
Net income 2021 97,7 M - -
Net cash 2021 596 M - -
P/E ratio 2021 121x
Yield 2021 -
Capitalization 11 311 M 11 311 M -
EV / Sales 2021 18,3x
EV / Sales 2022 15,3x
Nbr of Employees -
Free-Float 93,0%
Chart REPLIGEN CORPORATION
Duration : Period :
Repligen Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends REPLIGEN CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Last Close Price 206,01 $
Average target price 240,25 $
Spread / Average Target 16,6%
EPS Revisions
Managers and Directors
Tony J. Hunt President, Chief Executive Officer & Director
Jon K. Snodgres Chief Financial Officer
Karen T. Dawes Chairman
Ralf Kuriyel Senior Vice President-Research & Development
James R. Bylund Senior Vice President-Global Operations & IT
Sector and Competitors
1st jan.Capi. (M$)
REPLIGEN CORPORATION9.54%10 521
ABBOTT LABORATORIES10.33%200 283
MEDTRONIC PLC9.73%168 081
BECTON, DICKINSON AND COMPANY0.34%70 145
HOYA CORPORATION5.96%50 251
ALIGN TECHNOLOGY, INC.19.44%48 667